Product Recalls: November 13, 2024 – December 18, 2024
Health Letter, January 2025
Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.
For Class 1 recalls, there is a potential for serious injury or death.
For Class 2 recalls, there is a potential for serious adverse events but a lower chance of the drug causing serious injury or death than in a Class 1 recall.
CLASS I
CLASS II
aspirin chewable tablets, 81 mg, 1 tablet in blister card-foils, 100-count unit dose box. Manufactured by: Safecor Health, LLC. Lot #: 24A0061, exp. date: 05/23/2026.
calcium carbonate chewable tablets, 500 mg, 1 tablet in blister card-foils, 100-count unit dose box. Manufactured by: Safecor Health, LLC. Lot #: 24A0073, exp. date: 06/28/2026.
cinacalcet tablets; 30, 60 or 90 mg; 30- or 500-count HDPE bottle. Distributed by: Aurobindo Pharma USA, Inc. or Manufactured for: AvKARE. Lot #: CFSB23001A, exp. date: 03/31/2025; Lot #: CFSB23002A, exp. date: 07/31/2025; Lot #: CFSB23003A, exp. date: 10/31/2025; Lot #: CFSB23004A, exp. date: 10/31/2025; Lot #: P2300196, exp. date: 12/31/2024; Lot #: CFSC23001A or CFSC23001B, exp. date: 03/31/2025; Lot #: P2300195, exp. date: 12/31/2024; Lot #: 44378, 44597 or 45804, exp. date: 12/31/2024; Lot #: 44550, exp. date: 12/31/2024; Lot #: 44405, exp. date: 12/31/2024.
dabigatran etexilate capsules, 75 or 150 mg, 60-count bottles. Manufactured by: Alkem Laboratories Ltd. Lot #: 24142328, 24142329 or 24142330, exp. date: May 31, 2026; Lot #: 24142192, 24142193 or 24142194, exp. date: April 30, 2026; Lot #: 24142463, exp. date: May 31, 2026.
diltiazem hydrochloride extended-release capsules; 60, 90 or 120 mg, 100 capsules per bottle. Manufactured for: Glenmark Pharmaceuticals Inc or Northstar Rx LLC. Lot #: 17222544, exp. date: 11/30/2024; Lot #: 17230784, exp. date: 03/31/2025; Lot #: 17231080, exp. date: 04/30/2025; Lot #: 17222452, exp. date: 11/30/2024; Lot #: 17230607, exp. date: 02/28/2025; Lot #: 17222470, 17230680 or 17222547, exp. date: 11/30/2024; Lot #: 17230304, exp. date: 12/31/2024; Lot #: 17230598, exp. date: 02/2025; Lot #: 17222544, exp. date: 11/30/2024; Lot #: 17222452, exp date: 11/30/2024; Lot #: 17230607, exp date: 02/28/2025; Lot #: 17222547, exp. date: 11/30/2024; Lot #: 17230598, exp. date: 02/28/2025.
docusate sodium capsules, 250 mg, 1 softgel in blister card-foils, 100-count unit dose box. Manufactured by: Safecor Health, LLC. Lot #: 34A0054, exp. date: 05/07/2026.
duloxetine delayed-release capsules; 20, 30 or 60 mg; 30-, 60-, 90- or 1,000-count bottles. Distributed by: Rising Pharma Holdings, Inc. or Manufactured by: Aurobindo Pharma Limited. Lot #: DT2022023A, DT2022024A, DT2022025A, DT2022026A or DT2022027A, exp. date: Nov-24; Lot #: DT2023001B, DT2023004A, DT2023005A or DT2023006A, exp. date: Jan-25; Lot #: DT3023019A, exp. date: Jan-25; Lot #: DT3023050A, exp. date: Apr-25; Lot #: DT3023022A, exp. date: Jan-25; Lot #: DT3022108A, DT3022107A, DT3022106A, DT3022111A or DT3022109A, exp. date: Nov-24; Lot #: DT3023001A or DT3023003A, exp. date: Dec-24; Lot #: DT3023024A or DT3023020B, exp. date: Jan-25; Lot #: DT3023027A or DT3023028A, exp. date: Feb-25; Lot #: DT3023034A, exp. date: Mar-25; Lot #: DT3023049A, exp. date: Apr-25; Lot #: DT3023095A, exp. date: Jul-25; Lot #: DT6023059A, DT6023060A, DT6023065A, DT6023069A or DT6023070A, exp. date: Jan-25; Lot #: DT6023080A, exp. date: Feb-25; Lot #: DT6023093A, exp. date: Mar-25; Lot #: DTC24012A, exp. date: Dec-25; Lot #: DT6023108A, exp. date: Apr-25; Lot #: DTC23201A, exp. date: Aug-25; Lot #: DT6022160A, DT6022165A, DT6022162A, DT6022164A, DT6022163A, DT6022171A, DT6022169A, DT6022170A or DT6022173A, exp. date: Nov-24; Lot #: DT6023009A, DT6023007A, DT6023008A, DT6023011A or DT6023034B, exp. date: Dec-24; Lot #: DT6023067C, exp. date: Jan-25; Lot #: DT6023114A, exp. date: Apr-25; Lot #: DTC23243A, exp. date: Oct-25; Lot #: DTC24040A, exp. date: Dec-25; Lot #: DT2023001A or DT2023009A, exp. date: Jan 31, 2025; Lot #: DT3023019B or DT3023020A, exp. date: 01/31/2025; Lot #: DTB23098A, exp. date: 08/31/2025; Lot #: DT6022159A, DT6022167A or DT6022168A, exp. date: 11/30/2024; Lot #: DT6023034A, exp. date: 12/31/2024; Lot #: DT6023050A, DT6023051A, DT6023063A or DT6023067A, exp. date: 01/31/2025; Lot #: DT6023073A or DT6023072A, exp. date: 02/28/2025.
Kirkland Severe Cold & Flu Plus Congestion: Day – 112 coated caplets blister pack (acetaminophen 325 mg, dextromethorphan HBr 10 mg, guaifenesin 200 mg, phenylephrine HCl 5 mg); Night – 56 coated caplets blister pack (acetaminophen 325 mg, dextromethorphan HBr 10 mg, doxylamine succinate 6.25 mg, phenylephrine HCl 5 mg). Manufactured by: LNK International, Inc. Lot #: P139953, exp. date: 2026/AUG; Lot #; P139815, exp. date: 2026/AUG.
lanthanum carbonate chewable tablets, 1,000 mg, 10-count bottle. Manufactured for: Cipla USA or Exelan Pharmaceuticals. Lot #: NB240316, exp. date: 12/31/25; Lot #: NB240873, exp. date: 03/31/2026.
levothyroxine sodium tablets; 25, 50, 75, 88, 100, 112, 125, 137, 150, 175 or 200 mcg; 90-, 100- or 1,000-count bottle or blister card, Manufactured for: Accord Healthcare, Inc. Manufactured by: Intas Pharmaceuticals Limited or Mylan Pharmaceuticals Inc. Lot #: D2300191, exp. date: 12/31/2025; Lot #: 3182797, exp. date: Nov 2024; Lot #: 8177587 or 3199816, exp. date: Jun 2025; Lot #: 8165919, exp. date: Dec 2024; Lot #: 8172050, exp. date: Mar 2025; Lot #: 8183251, exp. date: Sept 2025; Lot #: 3185542, exp. date: Dec 2024; Lot #: 3192838, exp. date: Mar 2025; Lot #: 3208172, exp. date: Sept 2025; Lot #: 8177720, exp. date: Jun 2025; Lot #: 3200218, exp. date: Jun 2025; Lot #: 3192915 or 8172108, exp. date: Mar 2025; Lot #: 3208680, exp. date: Sep 2025; Lot #: 8179847, exp. date: July 2025; Lot #: 3203518, exp. date: July 2025; Lot #: 8181875, exp. date: Aug 2025; Lot #: 8174497, exp. date: April 2025; Lot #: 3209099, exp. date: Sep 2025; Lot #: 3206534, exp. date: Aug 2025; Lot #: 3196137, exp. date: April 2025; Lot #: 8174701, exp. date: April 2025; Lot #: 8182228, exp. date: Aug 2025; Lot #: 3193984, exp. date: Mar 2025; Lot #: 3206790, exp. date: Aug 2025; Lot #: 8177078, exp. date: May 2025; Lot #: 8168596, exp. date: Jan 2025; Lot #: 3199313, exp. date: May 2025; Lot #: 3194118, exp. date: Mar 2025; Lot #: 3186238, exp. date: Dec 2024; Lot #: 3209590, exp. date: Sep 2025; Lot #: 3199317, exp. date: May 2025; Lot #: 3188733, exp. date: Jan 2025; Lot #: 8180781, exp. date: Aug 2025; Lot #: 3191628, exp. date: Feb 2025; Lot #: 3197139, exp. date: Apr 2025; Lot #: 3188976, exp. date: Jan 2025; Lot #: 3184929, exp. date: Dec 2024; Lot #: 3204909, exp. date: Aug 2025; Lot #: 8171269, exp. date: Feb 2025; Lot #: 8179579, exp. date: July 2025; Lot #: 3183815, exp. date: Nov 2024; Lot #: 3189147, exp. date: Jan 2025; Lot #: 3192027, exp. date: Feb 2025; Lot #: 3202894, exp. date: Jul 2025; Lot #: 3192026, exp. date: Feb 2025; Lot #: 3199781, exp. date: Jun 2025; Lot #: 3192028, exp. date: Feb 2025; Lot #: 3202895, exp. date: July 2025; Lot #: 8171623, exp. date: Feb 2025; Lot #: 8164486, exp. date: Nov 2024; Lot #: 3205462, exp. date: Aug 2025; Lot #: 3192428, exp. date: Feb 2025; Lot #: 3184096, exp. date: Nov 2024; Lot #: 3115936, exp. date: 07/2025; Lot #: 3115707, exp. date: 02/2025; Lot #: 3115893, exp. date: 6/2025; Lot #: 3115448, exp. date: 12/31/2024; Lot #: 3115732, exp. date: 3/31/2025; Lot #: 3116024, exp. date: 9/30/2025; Lot #: 3115924, exp. date: 06/2025; Lot #: 3115869, exp. date: 03/2025.
lisdexamfetamine dimesylate capsules, 10 mg, 100 capsules per bottle. Distributed by: Lannet Company. Lot #: 23274856A, exp. date: 04/30/2025.
lisinopril tablets, 10 mg, 90 tablets per bottle. Manufactured for: Camber Pharmaceuticals. Lot #: 241103, exp. date: 05/31/2026.
ramipril capsules; 2.5, 5 or 10 mg; 90-, 100- or 500-count bottles. Manufactured for Lupin Pharmaceuticals, Inc. Lot #: G326781, exp. date: 30-Sep-25; Lot #: GA04468, exp. date: 31-May-25; Lot #: G326763, exp. date: 30-Sep-25; Lot #: GA03041, exp. date: 31-Mar-26; Lot #: GA03725, exp. date: 30-Apr-26; Lot #: GA04402, exp. date: 31-May-26; Lot #: G326782, exp. date: 30-Sep-25; Lot #: GA04462, exp. date: 31-May-26; Lot #: G326928, exp. date: 30-Sep-25; Lot #: GA00964, exp. date: 31-Dec-25; Lot #: G326897 or G326929, exp. date: 30-Sep-25; Lot #: GA00854, GA00933 or GA00954, exp. date: 31-Dec-25; Lot #: GA00955, exp. date: 31-Dec-25; Lot #: G327086, exp. date: 30-Sep-25; Lot #: GA01065, exp. date: 31-Dec-25; Lot #: G325033 or G324987, exp. date: 31-Jul-25; Lot #: G325110, GA00956, GA01066 or GA01126, exp. date: 31-Dec-25; GA03299, GA03288 or GA03287, exp. date: 31-Mar-26; Lot #: GA05919, exp. date: 31-Jul-26; Lot #: G327131, exp. date: 30-Sep-25.
sunitinib malate capsules, 12.5 or 25 mg, 28-count bottles. Manufactured for: AvKARE. Lot #: 100049371, exp. date: 07/31/2026. Lot #: 100049501, exp. date: 07/31/2026.
vitamin B1 tablets, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box. Manufactured by: Safecor Health, LLC. Lot #: 24A0050, exp. date: 04/25/2026; Lot #: 24A0055, exp. date: 05/09/2026; Lot #: 24A0059, exp. date: 05/16/2026; Lot #: 24A0060, exp. date: 05/20/2026; Lot #: 24A0071, exp. date: 06/24/2026; Lot #: 24A0072, exp. date: 06/26/2026.
vitamin D3 tablets, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box. Manufactured by: Safecor Health, LLC. Lot #: 24A0052, exp. date: 05/01/2026; Lot #: 24A0057, exp. date: 05/13/2026; Lot #: 24A0066, exp. date: 05/31/2026; Lot #: 24A0067, exp. date: 06/04/2026; Lot #: 24A0068, exp. date: 06/17/2026; Lot #: 24A0069, exp. date: 06/19/2026; Lot #: 24A0075, exp. date: 07/08/2026; Lot #: 24A0078, exp. date: 07/12/2026.
For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.
CONSUMER PRODUCTS
For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.